| PHAR Stock | | | USD 10.01 0.48 5.04% |
Pharming Group financial indicator trend analysis is much more than just breaking down Pharming Group NV prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Pharming Group NV is a good investment. Please check the relationship between Pharming Group Capital Expenditures and its Depreciation accounts. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pharming Group NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in nation.
Capital Expenditures vs Depreciation
Capital Expenditures vs Depreciation Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Pharming Group NV Capital Expenditures account and
Depreciation. At this time, the significance of the direction appears to have very week relationship.
The correlation between Pharming Group's Capital Expenditures and Depreciation is 0.2. Overlapping area represents the amount of variation of Capital Expenditures that can explain the historical movement of Depreciation in the same time period over historical financial statements of Pharming Group NV, assuming nothing else is changed. The correlation between historical values of Pharming Group's Capital Expenditures and Depreciation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Expenditures of Pharming Group NV are associated (or correlated) with its Depreciation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Depreciation has no effect on the direction of Capital Expenditures i.e., Pharming Group's Capital Expenditures and Depreciation go up and down completely randomly.
Correlation Coefficient | 0.2 |
| Relationship Direction | Positive |
| Relationship Strength | Very Weak |
Capital Expenditures
Capital Expenditures are funds used by Pharming Group NV to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Pharming Group operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.
Depreciation
Depreciation indicates how much of Pharming Group NV value has been used up. For tax purposes Pharming Group can deduct the cost of the tangible assets it purchases as business expenses. However, Pharming Group NV must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.
Most indicators from Pharming Group's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Pharming Group NV current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pharming Group NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in nation.
At this time, Pharming Group's
Selling General Administrative is relatively stable compared to the past year. As of 01/18/2025,
Issuance Of Capital Stock is likely to grow to about 4
M, while
Tax Provision is likely to drop (1.8
M).
Pharming Group fundamental ratios Correlations
Click cells to compare fundamentals
Pharming Group Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Pharming Group fundamental ratios Accounts
Additional Tools for Pharming Stock Analysis
When running Pharming Group's price analysis, check to
measure Pharming Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharming Group is operating at the current time. Most of Pharming Group's value examination focuses on studying past and present price action to
predict the probability of Pharming Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharming Group's price. Additionally, you may evaluate how the addition of Pharming Group to your portfolios can decrease your overall portfolio volatility.